Determining the time to cholangiocarcinoma in pediatric‐onset PSC‐IBD
Batul Kaj‐Carbaidwala(Massachusetts General Hospital), Jochen K. Lennerz(Addgene), Kate D. Lynch(University of Oxford), Annika Bergquist(Karolinska University Hospital), Roger W. Chapman, Corinne Gower‐Rousseau(Centre Hospitalier Universitaire de Reims), Lipika Goyal(Stanford Medicine), Uzma Shah(Massachusetts General Hospital), Lissy de Ridder(Erasmus MC - Sophia Children’s Hospital), David C. Wilson(University of Edinburgh), Johan Fevery(KU Leuven), Harland S. Winter(Massachusetts General Hospital), Catherine A. Stedman(Christchurch Hospital), Douglas G. Adler(Porter Adventist Hospital), Mark Deneau(Children's Hospital of Wisconsin)
Cited by 3
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k